Thirupath Reddy, MD
Cardiovascular Disease (Cardiology) · Fremont
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
On the public record
- 1 Medical Board action on record
Offices
2 locations · California Cardiovascular Consultants · Washington Township Hospital District
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Reddy’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54174 · Current
Licensed to practise in California · since 1995 · expires 2028-11-30 · Osmania University, Kakatiya Medical College. Board flags: Public Reprimand.
Public record actions
| 2018-12-14 | Board disciplineDiscipline | Public reprimand. · 8002014006672 |
Surgery centers they own
- Advanced Interventional Surgical CenterAmbulatory Surgery Center · Fremont, CA8.7% owner since 2015 · accredited by AAAHCAccreditation Renewed4 inspections, 4 with deficiencies · last 2025-10-21
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$215,148
Medicare paid this office $215,148 for 1,189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 314 | $60,244 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 116 | $28,103 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $15,610 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $11,568 | $173 |
| Short return visit (20+ min) | 138 | $11,342 | $69 |
See all 22 services
| Return visit (30+ min) | 314 | $60,244 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 116 | $28,103 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $15,610 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $11,568 | $173 |
| Short return visit (20+ min) | 138 | $11,342 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 138 | $11,319 | $48 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $9,082 | $413 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $8,860 | $57 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 41 | $5,624 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 631 | $5,214 | $7 |
| New patient visit (45+ min) | 43 | $5,017 | $117 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $4,629 | $356 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,570 | $105 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $3,513 | $207 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 17 | $2,591 | $76 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,239 | $187 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 22 | $875 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $789 | $56 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $331 | $9 |
| Blood test, comprehensive group of blood chemicals | 14 | $145 | $10 |
| Insertion of needle into vein for collection of blood sample | 15 | $130 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 12 | $91 | $8 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 42 | More than 86% of doctors who do this |
Who their Medicare patients are
1,189 Original Medicare patients in 2024. Average age 78 · Under 65 7% · 85 and older 27% · Women 56% · Also on Medicaid 54% · Health risk score 2.28. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 56% · Coronary heart disease 52% · Chronic kidney disease 44% · Heart failure 43% · Atrial fibrillation 39% · COPD 27% · Dementia 22% · Depression 21% · Stroke 21% · Cancer 16%.
The office billed $804,982, Medicare allowed $290,123 and paid $215,148; for 3,289 services of 70 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,189 | 3,289 | 78 | 2.28 | $804,982 | $215,148 |
| 2023 | 1,182 | 3,737 | 78 | 2.12 | $722,317 | $221,509 |
| 2022 | 1,081 | 3,594 | 77 | 2.15 | $730,841 | $220,380 |
| 2021 | 1,194 | 4,190 | 77 | 2.10 | $858,796 | $276,549 |
| 2020 | 1,145 | 3,664 | 77 | 2.40 | $765,039 | $234,607 |
| 2019 | 1,147 | 3,784 | 77 | 2.32 | $799,679 | $250,582 |
| 2018 | 1,146 | 4,281 | 77 | 2.38 | $817,827 | $244,201 |
| 2017 | 1,748 | 4,957 | 77 | 2.30 | $948,362 | $282,003 |
| 2016 | 1,789 | 4,933 | 77 | 2.33 | $929,814 | $266,240 |
| 2015 | 1,755 | 5,130 | 77 | 2.18 | $989,458 | $276,104 |
| 2014 | 1,750 | 5,169 | 77 | 2.17 | $1,075,147 | $297,645 |
| 2013 | 1,342 | 3,909 | 76 | 2.38 | $913,739 | $296,023 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 295 | $63,838 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 124 | $21,204 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $20,165 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $13,211 | $191 |
| Short return visit (20+ min) | 121 | $11,619 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $11,459 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 131 | $11,364 | $55 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $9,256 | $463 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 49 | $7,709 | $69 |
| New patient visit (45+ min) | 49 | $6,501 | $133 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,336 | $381 |
| Insertion of permanent leadless pacemaker using imaging guidance | 13 | $4,911 | $378 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 613 | $4,766 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $3,554 | $237 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,561 | $183 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | $1,113 | $38 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $818 | $28 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 22 | $309 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $254 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $181 | $14 |
| Blood test, comprehensive group of blood chemicals | 13 | $155 | $10 |
| Insertion of needle into vein for collection of blood sample | 16 | $151 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $122 | $8 |
2022: 25 services
| Return visit (30+ min) | 318 | $63,985 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $22,283 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 116 | $21,185 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $12,980 | $183 |
| Short return visit (20+ min) | 119 | $11,592 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 125 | $10,974 | $50 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $8,050 | $474 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 56 | $7,468 | $69 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,222 | $425 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $5,997 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 557 | $4,672 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,883 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,572 | $92 |
| New patient visit (45+ min) | 27 | $3,128 | $116 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,391 | $217 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 32 | $1,529 | $31 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 20 | $1,166 | $22 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $981 | $52 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $971 | $20 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 18 | $761 | $38 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 18 | $401 | $20 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 16 | $234 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $205 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $164 | $14 |
| Insertion of needle into vein for collection of blood sample | 12 | $38 | $3 |
2021: 30 services
| Return visit (30+ min) | 355 | $79,306 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $20,409 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $20,030 | $179 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 35 | $14,778 | $422 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 69 | $13,805 | $200 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 200 | $13,260 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 140 | $12,044 | $51 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $11,571 | $503 |
| Short return visit (20+ min) | 119 | $11,483 | $78 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 54 | $8,118 | $67 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $4,998 | $238 |
| Removal and replacement of dual lead permanent pacemaker | 16 | $4,763 | $298 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 549 | $4,566 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,200 | $221 |
| New patient visit (45+ min) | 33 | $4,193 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,977 | $92 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 41 | $2,130 | $24 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 20 | $1,890 | $95 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 39 | $1,848 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 34 | $1,735 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,697 | $121 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 34 | $1,361 | $25 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 11 | $1,074 | $28 |
| New patient visit (30+ min) | 12 | $1,000 | $83 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 20 | $364 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $325 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $212 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $211 | $13 |
| Blood test, comprehensive group of blood chemicals | 11 | $116 | $11 |
| Insertion of needle into vein for collection of blood sample | 11 | $33 | $3 |
2020: 28 services
| Return visit (30+ min) | 331 | $54,891 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $25,841 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $22,616 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 213 | $14,013 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $12,858 | $195 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $9,091 | $455 |
| Short return visit (20+ min) | 124 | $8,589 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 119 | $7,412 | $44 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $7,275 | $485 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 59 | $6,730 | $60 |
| New patient visit (45+ min) | 40 | $5,901 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 453 | $3,632 | $7 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 18 | $3,610 | $34 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,716 | $209 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 59 | $2,346 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,971 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $1,890 | $94 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $1,850 | $32 |
| Long return visit (40+ min) | 11 | $1,514 | $138 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 15 | $1,449 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $1,435 | $25 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 14 | $1,014 | $25 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $474 | $40 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 12 | $245 | None |
| Blood test, comprehensive group of blood chemicals | 14 | $189 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $175 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $139 | $8 |
| Insertion of needle into vein for collection of blood sample | 18 | $75 | $3 |
2019: 28 services
| Return visit (30+ min) | 359 | $66,198 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 142 | $28,376 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $24,509 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $16,213 | $198 |
| Short return visit (20+ min) | 137 | $10,469 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $10,343 | $66 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,220 | $411 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $8,103 | $477 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 124 | $7,986 | $39 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 65 | $6,021 | $52 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,112 | $213 |
| New patient visit (45+ min) | 34 | $4,842 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 484 | $4,533 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,111 | $206 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 30 | $3,194 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,681 | $92 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 16 | $2,443 | $153 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 19 | $2,172 | $109 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $1,622 | $95 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $1,506 | $39 |
| Return visit (30+ min) | 21 | $1,400 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 29 | $962 | $27 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 12 | $263 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $240 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 17 | $152 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $147 | $13 |
| Blood test, comprehensive group of blood chemicals | 11 | $127 | $12 |
| Insertion of needle into vein for collection of blood sample | 21 | $71 | $3 |
2018: 30 services
| Return visit (30+ min) | 333 | $53,724 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 151 | $27,944 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $18,612 | $60 |
| Short return visit (20+ min) | 225 | $17,394 | $57 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | $15,527 | $471 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 227 | $14,269 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $12,532 | $193 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $10,110 | $389 |
| Insertion of implantable defibrillator system | 11 | $7,478 | $680 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $6,646 | $208 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 114 | $6,103 | $32 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 63 | $5,422 | $44 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,774 | $208 |
| New patient visit (45+ min) | 33 | $3,680 | $112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 425 | $3,493 | $7 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 33 | $3,290 | $89 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 17 | $2,650 | $147 |
| Return visit (30+ min) | 27 | $1,759 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,605 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,377 | $86 |
| New patient visit (30+ min) | 12 | $935 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $816 | $26 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $734 | $67 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 27 | $656 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $621 | $34 |
| Short return visit (20+ min) | 13 | $554 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $432 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $332 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $297 | $10 |
| Insertion of needle into vein for collection of blood sample | 15 | $53 | $3 |
2017: 32 services
| Return visit (30+ min) | 361 | $56,125 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 142 | $25,166 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 173 | $23,833 | $59 |
| Short return visit (20+ min) | 246 | $19,028 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $17,604 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $15,457 | $201 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,066 | $14,518 | $11 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $10,290 | $447 |
| Insertion of implantable defibrillator system | 15 | $9,826 | $655 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $9,533 | $87 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $8,069 | $367 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $6,564 | $243 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 60 | $5,953 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 122 | $5,883 | $31 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,642 | $470 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $4,242 | $90 |
| New patient visit (45+ min) | 27 | $3,116 | $115 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 16 | $2,269 | $142 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $2,155 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $1,207 | $25 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 11 | $1,204 | $109 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,183 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,066 | $67 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $846 | $77 |
| Measurement of brain wave activity (eeg), awake and asleep | 12 | $834 | $69 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $791 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $289 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $270 | $15 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $266 | $19 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 13 | $236 | None |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $146 | $10 |
| Insertion of needle into vein for collection of blood sample | 12 | $44 | $3 |
2016: 28 services
| Return visit (30+ min) | 366 | $67,307 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $31,504 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 153 | $25,911 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $14,534 | $199 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 228 | $12,333 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,143 | $10,290 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $9,978 | $434 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 23 | $9,633 | $419 |
| Short return visit (20+ min) | 131 | $9,187 | $55 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 63 | $6,522 | $52 |
| Removal and replacement of dual lead defibrillator | 18 | $5,391 | $299 |
| New patient visit (45+ min) | 37 | $4,813 | $130 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 113 | $4,764 | $29 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $4,389 | $95 |
| Initial hospital observation care per day, typically 70 minutes | 26 | $4,102 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $3,999 | $210 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 25 | $3,237 | $129 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,112 | $96 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,861 | $55 |
| Review by radiologist of arm or leg artery image | 26 | $1,276 | $46 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 44 | $1,261 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 28 | $835 | $28 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $794 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $310 | $15 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 13 | $269 | None |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $262 | $11 |
| Ultrasound of heart, follow-up | 11 | $242 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $210 | $12 |
2015: 32 services
| Return visit (30+ min) | 285 | $49,017 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 155 | $28,507 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 171 | $26,930 | $61 |
| Short return visit (20+ min) | 228 | $19,520 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 324 | $18,627 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 57 | $12,350 | $213 |
| Insertion of implantable defibrillator system | 15 | $11,501 | $767 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,114 | $11,030 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $8,090 | $449 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 66 | $7,981 | $55 |
| Removal and replacement of dual lead defibrillator | 25 | $7,905 | $316 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,795 | $433 |
| Initial hospital observation care per day, typically 70 minutes | 41 | $6,204 | $148 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 40 | $5,428 | $136 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 101 | $5,153 | $31 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,146 | $214 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 18 | $4,759 | $132 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $4,732 | $249 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $2,908 | $69 |
| New patient visit (45+ min) | 21 | $2,798 | $133 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,363 | $103 |
| Long return visit (40+ min) | 15 | $2,106 | $124 |
| Initial hospital observation care per day, typically 50 minutes | 14 | $1,611 | $115 |
| Review by radiologist of arm or leg artery image | 33 | $1,519 | $46 |
| Hospital discharge day management, 30 minutes or less | 13 | $870 | $62 |
| Measurement of brain wave activity (eeg), awake and asleep | 14 | $700 | $50 |
| Ultrasound of heart, follow-up | 24 | $555 | $22 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 17 | $442 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $429 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $362 | $12 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $180 | $11 |
| Insertion of needle into vein for collection of blood sample | 14 | $53 | $3 |
2014: 32 services
| Return visit (30+ min) | 277 | $42,446 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 193 | $35,192 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 190 | $28,844 | $63 |
| Short return visit (20+ min) | 289 | $28,154 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 415 | $23,707 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $11,777 | $218 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,045 | $10,608 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 72 | $9,455 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $9,383 | $447 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,319 | $424 |
| Insertion of implantable defibrillator system | 11 | $8,472 | $770 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $6,890 | $255 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $6,516 | $233 |
| Long return visit (40+ min) | 46 | $5,635 | $120 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $5,273 | $132 |
| Removal and replacement of dual lead defibrillator | 15 | $5,090 | $339 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 105 | $4,939 | $31 |
| Initial hospital observation care per day, typically 70 minutes | 31 | $4,863 | $152 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 24 | $3,981 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $2,628 | $69 |
| New patient visit (45+ min) | 18 | $2,549 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,544 | $91 |
| Review by radiologist of arm or leg artery image | 31 | $1,483 | $48 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 23 | $1,429 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,243 | $83 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 13 | $1,230 | None |
| Short return visit | 19 | $676 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 43 | $542 | $13 |
| Ultrasound of heart, follow-up | 16 | $356 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $200 | $13 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $170 | $11 |
| Insertion of needle into vein for collection of blood sample | 11 | $41 | $3 |
2013: 34 services
| Return visit (30+ min) | 316 | $57,256 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $35,735 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 167 | $30,797 | $167 |
| Short return visit (20+ min) | 268 | $24,933 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 222 | $13,200 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 61 | $11,417 | $178 |
| Insertion of implantable defibrillator system | 14 | $10,490 | $749 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 24 | $10,187 | $424 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 69 | $7,667 | $57 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $6,788 | $485 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $6,015 | $223 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 567 | $5,455 | $7 |
| Insertion of left lower heart electrode and attachment to pacemaker or defibrillator | 13 | $5,412 | $416 |
| Initial hospital observation care per day, typically 70 minutes | 34 | $5,205 | $149 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $4,229 | $132 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $4,139 | $230 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 86 | $4,062 | $32 |
| Long return visit (40+ min) | 30 | $3,865 | $129 |
| New patient visit (45+ min) | 20 | $2,745 | $137 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $2,517 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,307 | $85 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,139 | $89 |
| Initial hospital observation care per day, typically 50 minutes | 17 | $1,953 | $115 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 14 | $1,851 | $132 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $1,433 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,393 | $33 |
| Hospital discharge day management, 30 minutes or less | 15 | $931 | $62 |
| Review by radiologist of both arms or legs arteries image | 16 | $859 | $54 |
| Hospital observation care on day of discharge | 12 | $742 | $62 |
| Blood test, comprehensive group of blood chemicals | 13 | $203 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $186 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $186 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $168 | $11 |
| Insertion of needle into vein for collection of blood sample | 14 | $47 | $3 |
Medicaid work
$59,656 in 2024
Medicaid paid $59,656 for 1,625 billed services this clinician did in 2024, up to 165 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 364 | $26,003 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 215 | $8,914 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 157 | $7,862 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 657 | $5,789 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 142 | $4,736 |
| Short return visit (20+ min) | 44 | $3,199 |
| 1ST HOSP IP/OBS HIGH 75 | 46 | $3,155 |
| 2024 | 1,625 | 7 | 165 | $59,656 |
| 2023 | 1,643 | 7 | 187 | $52,450 |
| 2022 | 1,085 | 4 | 148 | $37,645 |
| 2021 | 1,118 | 5 | 132 | $37,842 |
| 2020 | 829 | 5 | 150 | $29,360 |
| 2019 | 808 | 4 | 136 | $25,056 |
| 2018 | 1,354 | 7 | 130 | $45,161 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 451 | $30,167 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 215 | $7,546 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 748 | $5,447 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $2,698 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 71 | $2,336 |
| Short return visit (20+ min) | 44 | $2,129 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $2,126 |
2022
| Return visit (30+ min) | 378 | $29,654 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 634 | $4,531 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 45 | $2,454 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 28 | $1,006 |
2021
| Return visit (30+ min) | 389 | $25,441 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 152 | $5,852 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 504 | $3,631 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 59 | $1,962 |
| Short return visit (20+ min) | 14 | $957 |
2020
| Return visit (30+ min) | 274 | $19,012 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 119 | $5,720 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 393 | $2,692 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 29 | $1,212 |
| Short return visit (20+ min) | 14 | $723 |
2019
| Return visit (30+ min) | 328 | $18,684 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 62 | $2,698 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 388 | $2,447 |
| Short return visit (20+ min) | 30 | $1,227 |
2018
| Return visit (30+ min) | 340 | $17,261 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 200 | $8,938 |
| Short return visit (20+ min) | 216 | $8,427 |
| 1ST HOSP IP/OBS HIGH 75 | 108 | $6,300 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 390 | $2,486 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 68 | $1,324 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 32 | $426 |
Drugs they prescribed that Part D paid
$504,914
Pharmacies billed $504,914 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,523) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,054 generic and 469 brand-name prescriptions · $504,914 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 255 | $290,139 | $1,138 |
| Xarelto | 60 | $73,286 | $1,221 |
| Entresto | 56 | $63,881 | $1,141 |
| Brilinta | 28 | $29,593 | $1,057 |
| Farxiga | 11 | $6,301 | $573 |
See all 26 drugs
| Eliquis | 255 | $290,139 | $1,138 |
| Xarelto | 60 | $73,286 | $1,221 |
| Entresto | 56 | $63,881 | $1,141 |
| Brilinta | 28 | $29,593 | $1,057 |
| Farxiga | 11 | $6,301 | $573 |
| Rosuvastatin | 30 | $1,608 | $54 |
| Metoprolol | 169 | $1,336 | $8 |
| Amiodarone | 21 | $1,252 | $60 |
| Atorvastatin | 97 | $976 | $10 |
| Albuterol Sulfate Hfa | 24 | $946 | $39 |
| Metoprolol | 47 | $829 | $18 |
| Clopidogrel | 51 | $810 | $16 |
| Nifedipine Er | 12 | $694 | $58 |
| Diltiazem 24hr Er (Cd) | 15 | $651 | $43 |
| Carvedilol | 62 | $617 | $10 |
| Potassium Chloride | 37 | $596 | $16 |
| Losartan | 60 | $542 | $9 |
| Hydralazine | 33 | $528 | $16 |
| Digoxin | 18 | $489 | $27 |
| Amlodipine Besylate | 44 | $409 | $9 |
| Lisinopril | 46 | $384 | $8 |
| Furosemide | 70 | $364 | $5 |
| Simvastatin | 42 | $299 | $7 |
| Pantoprazole | 19 | $263 | $14 |
| Pravastatin | 15 | $247 | $16 |
| Nitroglycerin | 12 | $215 | $18 |
Year by year
| 2024 | 1,523 | 246 | 0% (0) | 31% | $504,914 |
| 2023 | 1,549 | 231 | 0% (0) | 28% | $499,137 |
| 2022 | 1,472 | 223 | 0% (0) | 26% | $394,261 |
| 2021 | 1,623 | 259 | 0% (0) | None | $351,793 |
| 2020 | 1,688 | 267 | 0% (0) | 25% | $299,149 |
| 2019 | 1,555 | 239 | None | 24% | $253,692 |
| 2018 | 1,552 | 216 | None | 23% | $213,229 |
| 2017 | 2,003 | 251 | None | None | $192,096 |
| 2016 | 2,318 | 255 | None | None | $176,364 |
| 2015 | 2,374 | 266 | None | None | $149,364 |
| 2014 | 2,381 | 239 | 1% (22) | None | $136,730 |
| 2013 | 2,143 | 252 | 1% (20) | None | $116,962 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Eliquis | 265 | $308,848 | $1,165 |
| Entresto | 52 | $59,565 | $1,145 |
| Xarelto | 38 | $37,420 | $985 |
| Brilinta | 34 | $35,863 | $1,055 |
| Metoprolol | 159 | $2,209 | $14 |
| Rosuvastatin | 23 | $1,730 | $75 |
| Metoprolol | 48 | $1,672 | $35 |
| Carvedilol | 93 | $1,671 | $18 |
| Atorvastatin | 93 | $1,420 | $15 |
| Clopidogrel | 46 | $1,217 | $26 |
| Diltiazem 24hr Er (Cd) | 21 | $1,185 | $56 |
| Losartan | 74 | $1,181 | $16 |
| Hydralazine | 51 | $1,137 | $22 |
| Amiodarone | 21 | $991 | $47 |
| Digoxin | 22 | $986 | $45 |
| Potassium Chloride | 32 | $970 | $30 |
| Amlodipine Besylate | 43 | $850 | $20 |
| Lisinopril | 57 | $762 | $13 |
| Simvastatin | 47 | $755 | $16 |
| Furosemide | 70 | $707 | $10 |
| Pravastatin | 25 | $667 | $27 |
| Pantoprazole | 16 | $575 | $36 |
| Diltiazem | 11 | $343 | $31 |
| Lisinopril-Hydrochlorothiazide | 12 | $328 | $27 |
| Levothyroxine | 12 | $187 | $16 |
| Spironolactone | 13 | $159 | $12 |
2022: 27 drugs
| Eliquis | 248 | $270,850 | $1,092 |
| Entresto | 27 | $30,535 | $1,131 |
| Brilinta | 35 | $25,574 | $731 |
| Pradaxa | 11 | $13,361 | $1,215 |
| Metoprolol | 136 | $1,637 | $12 |
| Carvedilol | 89 | $1,342 | $15 |
| Diltiazem 24hr Er (Cd) | 29 | $1,276 | $44 |
| Atorvastatin | 84 | $1,248 | $15 |
| Metoprolol | 38 | $1,202 | $32 |
| Amiodarone | 23 | $1,201 | $52 |
| Losartan | 79 | $1,125 | $14 |
| Rosuvastatin | 15 | $882 | $59 |
| Digoxin | 18 | $832 | $46 |
| Lisinopril | 77 | $776 | $10 |
| Amlodipine Besylate | 39 | $668 | $17 |
| Potassium Chloride | 22 | $646 | $29 |
| Clopidogrel | 47 | $644 | $14 |
| Furosemide | 76 | $613 | $8 |
| Pravastatin | 26 | $582 | $22 |
| Simvastatin | 51 | $559 | $11 |
| Hydralazine | 25 | $403 | $16 |
| Warfarin | 13 | $344 | $26 |
| Isosorbide Mononitrate Er | 14 | $311 | $22 |
| Pantoprazole | 13 | $295 | $23 |
| Tamsulosin | 14 | $262 | $19 |
| Atenolol | 18 | $194 | $11 |
| Hydrochlorothiazide | 15 | $136 | $9 |
2021: 31 drugs
| Eliquis | 241 | $212,251 | $881 |
| Entresto | 31 | $30,604 | $987 |
| Xarelto | 21 | $24,205 | $1,153 |
| Pradaxa | 15 | $14,357 | $957 |
| Brilinta | 22 | $13,523 | $615 |
| Amiodarone | 17 | $2,341 | $138 |
| Metoprolol | 51 | $1,847 | $36 |
| Sotalol | 11 | $1,329 | $121 |
| Metoprolol | 152 | $1,317 | $9 |
| Carvedilol | 87 | $1,233 | $14 |
| Atorvastatin | 89 | $1,208 | $14 |
| Diltiazem 24hr Er (Cd) | 22 | $1,203 | $55 |
| Digoxin | 23 | $1,136 | $49 |
| Losartan | 72 | $906 | $13 |
| Simvastatin | 63 | $899 | $14 |
| Potassium Chloride | 29 | $786 | $27 |
| Clopidogrel | 59 | $672 | $11 |
| Lisinopril | 80 | $661 | $8 |
| Pravastatin | 31 | $598 | $19 |
| Hydralazine | 31 | $580 | $19 |
| Furosemide | 87 | $578 | $7 |
| Rosuvastatin | 15 | $531 | $35 |
| Amlodipine Besylate | 37 | $431 | $12 |
| Diltiazem | 18 | $431 | $24 |
| Warfarin | 22 | $348 | $16 |
| Pantoprazole | 13 | $344 | $26 |
| Isosorbide Mononitrate Er | 13 | $309 | $24 |
| Tamsulosin | 15 | $302 | $20 |
| Levothyroxine | 12 | $239 | $20 |
| Atenolol | 17 | $225 | $13 |
| Hydrochlorothiazide | 24 | $191 | $8 |
2020: 31 drugs
| Eliquis | 217 | $180,413 | $831 |
| Xarelto | 33 | $34,699 | $1,051 |
| Entresto | 19 | $16,622 | $875 |
| Pradaxa | 12 | $16,137 | $1,345 |
| Metoprolol | 59 | $1,748 | $30 |
| Atorvastatin | 98 | $1,606 | $16 |
| Digoxin | 35 | $1,319 | $38 |
| Isosorbide Dinitrate | 13 | $1,254 | $96 |
| Carvedilol | 105 | $1,191 | $11 |
| Metoprolol | 145 | $1,119 | $8 |
| Losartan | 89 | $1,098 | $12 |
| Nitroglycerin | 21 | $958 | $46 |
| Diltiazem 24hr Er (Cd) | 16 | $869 | $54 |
| Clopidogrel | 65 | $864 | $13 |
| Hydralazine | 29 | $769 | $27 |
| Simvastatin | 51 | $747 | $15 |
| Metolazone | 11 | $704 | $64 |
| Furosemide | 95 | $651 | $7 |
| Ventolin Hfa | 11 | $635 | $58 |
| Amiodarone | 12 | $567 | $47 |
| Pravastatin | 26 | $507 | $20 |
| Lisinopril | 74 | $495 | $7 |
| Potassium Chloride | 21 | $489 | $23 |
| Warfarin | 21 | $420 | $20 |
| Tamsulosin | 23 | $362 | $16 |
| Pantoprazole | 17 | $334 | $20 |
| Amlodipine Besylate | 52 | $333 | $6 |
| Isosorbide Mononitrate Er | 12 | $221 | $18 |
| Atenolol | 16 | $191 | $12 |
| Omeprazole | 13 | $159 | $12 |
| Hydrochlorothiazide | 18 | $140 | $8 |
2019: 28 drugs
| Eliquis | 160 | $124,892 | $781 |
| Xarelto | 33 | $31,550 | $956 |
| Pradaxa | 15 | $16,936 | $1,129 |
| Entresto | 18 | $14,015 | $779 |
| Brilinta | 19 | $12,883 | $678 |
| Metoprolol | 47 | $2,689 | $57 |
| Atorvastatin | 89 | $1,644 | $18 |
| Rosuvastatin | 11 | $1,333 | $121 |
| Carvedilol | 105 | $1,330 | $13 |
| Hydralazine | 33 | $1,237 | $37 |
| Clopidogrel | 67 | $1,224 | $18 |
| Metoprolol | 145 | $1,182 | $8 |
| Digoxin | 24 | $1,139 | $47 |
| Isosorbide Dinitrate | 14 | $1,122 | $80 |
| Pravastatin | 27 | $1,001 | $37 |
| Potassium Chloride | 21 | $936 | $45 |
| Nitroglycerin | 16 | $906 | $57 |
| Lisinopril | 82 | $792 | $10 |
| Simvastatin | 65 | $765 | $12 |
| Furosemide | 97 | $733 | $8 |
| Losartan | 70 | $720 | $10 |
| Amiodarone | 16 | $675 | $42 |
| Warfarin | 25 | $522 | $21 |
| Isosorbide Mononitrate Er | 14 | $407 | $29 |
| Tamsulosin | 11 | $267 | $24 |
| Amlodipine Besylate | 36 | $209 | $6 |
| Pantoprazole | 16 | $202 | $13 |
| Atenolol | 14 | $167 | $12 |
2018: 29 drugs
| Eliquis | 156 | $94,446 | $605 |
| Pradaxa | 31 | $26,187 | $845 |
| Xarelto | 26 | $17,194 | $661 |
| Brilinta | 18 | $13,726 | $763 |
| Metoprolol | 33 | $2,215 | $67 |
| Atorvastatin | 73 | $1,495 | $20 |
| Digoxin | 24 | $1,474 | $61 |
| Clopidogrel | 68 | $1,281 | $19 |
| Metoprolol | 165 | $1,270 | $8 |
| Potassium Chloride | 25 | $1,203 | $48 |
| Isosorbide Dinitrate | 12 | $1,148 | $96 |
| Simvastatin | 71 | $937 | $13 |
| Pravastatin | 24 | $929 | $39 |
| Carvedilol | 119 | $883 | $7 |
| Warfarin | 42 | $841 | $20 |
| Cartia Xt | 15 | $734 | $49 |
| Lisinopril | 79 | $683 | $9 |
| Amiodarone | 12 | $590 | $49 |
| Furosemide | 82 | $581 | $7 |
| Hydralazine | 20 | $573 | $29 |
| Nitroglycerin | 12 | $546 | $45 |
| Isosorbide Mononitrate Er | 15 | $499 | $33 |
| Losartan | 48 | $478 | $10 |
| Valsartan-Hydrochlorothiazide | 15 | $444 | $30 |
| Amlodipine Besylate | 39 | $416 | $11 |
| Levothyroxine | 17 | $416 | $24 |
| Pantoprazole | 16 | $224 | $14 |
| Atenolol | 16 | $189 | $12 |
| Gabapentin | 13 | $128 | $10 |
2017: 33 drugs
| Eliquis | 136 | $80,837 | $594 |
| Pradaxa | 50 | $32,636 | $653 |
| Xarelto | 19 | $13,636 | $718 |
| Potassium Chloride | 46 | $2,153 | $47 |
| Digoxin | 41 | $2,017 | $49 |
| Metoprolol | 32 | $1,780 | $56 |
| Atorvastatin | 91 | $1,713 | $19 |
| Metoprolol | 211 | $1,617 | $8 |
| Clopidogrel | 119 | $1,606 | $13 |
| Isosorbide Dinitrate | 15 | $1,457 | $97 |
| Warfarin | 90 | $1,359 | $15 |
| Pravastatin | 37 | $1,156 | $31 |
| Amiodarone | 28 | $1,100 | $39 |
| Carvedilol | 125 | $1,051 | $8 |
| Lisinopril | 108 | $874 | $8 |
| Nitroglycerin | 13 | $866 | $67 |
| Valsartan-Hydrochlorothiazide | 15 | $819 | $55 |
| Simvastatin | 68 | $703 | $10 |
| Furosemide | 141 | $671 | $5 |
| Amlodipine Besylate | 53 | $488 | $9 |
| Losartan | 56 | $470 | $8 |
| Tamsulosin | 15 | $436 | $29 |
| Diltiazem Er | 12 | $390 | $32 |
| Isosorbide Mononitrate Er | 17 | $375 | $22 |
| Cartia Xt | 17 | $361 | $21 |
| Hydralazine | 16 | $339 | $21 |
| Atenolol | 32 | $309 | $10 |
| Allopurinol | 26 | $293 | $11 |
| Pantoprazole | 31 | $267 | $9 |
| Gabapentin | 25 | $178 | $7 |
| Omeprazole | 15 | $107 | $7 |
| Metformin | 14 | $102 | $7 |
| Hydrochlorothiazide | 11 | $35 | $3 |
2016: 38 drugs
| Eliquis | 121 | $50,912 | $421 |
| Pradaxa | 56 | $36,492 | $652 |
| Xarelto | 30 | $15,906 | $530 |
| Effient | 11 | $6,702 | $609 |
| Isosorbide Dinitrate | 30 | $2,886 | $96 |
| Benicar | 13 | $2,778 | $214 |
| Clopidogrel | 182 | $2,480 | $14 |
| Metoprolol | 48 | $2,368 | $49 |
| Amiodarone | 42 | $1,865 | $44 |
| Digoxin | 34 | $1,850 | $54 |
| Warfarin | 107 | $1,658 | $15 |
| Potassium Chloride | 49 | $1,638 | $33 |
| Atorvastatin | 78 | $1,556 | $20 |
| Carvedilol | 163 | $1,537 | $9 |
| Omega-3 Acid Ethyl Esters | 11 | $1,408 | $128 |
| Metoprolol | 200 | $1,305 | $7 |
| Pravastatin | 43 | $1,245 | $29 |
| Simvastatin | 91 | $951 | $10 |
| Lisinopril | 113 | $915 | $8 |
| Furosemide | 141 | $837 | $6 |
| Amlodipine Besylate | 81 | $752 | $9 |
| Tamsulosin | 22 | $718 | $33 |
| Losartan | 59 | $652 | $11 |
| Valsartan | 13 | $649 | $50 |
| Cartia Xt | 11 | $487 | $44 |
| Atenolol | 52 | $454 | $9 |
| Diltiazem Er | 19 | $391 | $21 |
| Sotalol | 20 | $364 | $18 |
| Valsartan-Hydrochlorothiazide | 11 | $322 | $29 |
| Isosorbide Mononitrate Er | 19 | $312 | $16 |
| Allopurinol | 26 | $281 | $11 |
| Omeprazole | 21 | $236 | $11 |
| Hydralazine | 12 | $225 | $19 |
| Gabapentin | 15 | $219 | $15 |
| Lovastatin | 15 | $179 | $12 |
| Trandolapril | 12 | $174 | $15 |
| Alendronate | 15 | $137 | $9 |
| Hydrochlorothiazide | 13 | $73 | $6 |
2015: 41 drugs
| Pradaxa | 87 | $38,618 | $444 |
| Eliquis | 51 | $19,542 | $383 |
| Xarelto | 39 | $17,334 | $444 |
| Effient | 15 | $5,444 | $363 |
| Spiriva | 11 | $4,011 | $365 |
| Benicar | 15 | $3,212 | $214 |
| Ranexa | 16 | $2,915 | $182 |
| Metoprolol | 52 | $2,660 | $51 |
| Isosorbide Dinitrate | 29 | $2,567 | $89 |
| Atorvastatin | 104 | $2,394 | $23 |
| Clopidogrel | 168 | $2,367 | $14 |
| Potassium Chloride | 58 | $2,084 | $36 |
| Warfarin | 138 | $1,873 | $14 |
| Digoxin | 27 | $1,762 | $65 |
| Carvedilol | 164 | $1,322 | $8 |
| Simvastatin | 120 | $1,285 | $11 |
| Metoprolol | 188 | $1,187 | $6 |
| Lisinopril | 158 | $1,068 | $7 |
| Omega-3 Acid Ethyl Esters | 11 | $1,029 | $94 |
| Valsartan | 12 | $978 | $81 |
| Pravastatin | 28 | $912 | $33 |
| Furosemide | 125 | $697 | $6 |
| Amlodipine Besylate | 60 | $627 | $10 |
| Isosorbide Mononitrate Er | 29 | $589 | $20 |
| Losartan | 48 | $505 | $11 |
| Digox | 13 | $454 | $35 |
| Diltiazem Er | 15 | $438 | $29 |
| Levothyroxine | 15 | $421 | $28 |
| Omeprazole | 37 | $401 | $11 |
| Amiodarone | 31 | $362 | $12 |
| Hydralazine | 19 | $350 | $18 |
| Atenolol | 37 | $318 | $9 |
| Gabapentin | 15 | $289 | $19 |
| Pantoprazole | 17 | $289 | $17 |
| Metformin | 23 | $248 | $11 |
| Famotidine | 25 | $238 | $10 |
| Allopurinol | 14 | $218 | $16 |
| Hydrochlorothiazide | 22 | $177 | $8 |
| Lactulose | 12 | $120 | $10 |
| Spironolactone | 14 | $102 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $65 | $5 |
2014: 41 drugs
| Pradaxa | 77 | $35,700 | $464 |
| Xarelto | 38 | $18,218 | $479 |
| Eliquis | 16 | $4,369 | $273 |
| Spiriva | 13 | $3,866 | $297 |
| Metoprolol | 44 | $3,215 | $73 |
| Clopidogrel | 128 | $2,829 | $22 |
| Benicar | 11 | $2,054 | $187 |
| Isosorbide Dinitrate | 22 | $2,054 | $93 |
| Digoxin | 27 | $1,860 | $69 |
| Atorvastatin | 88 | $1,734 | $20 |
| Carvedilol | 168 | $1,692 | $10 |
| Metoprolol | 202 | $1,632 | $8 |
| Warfarin | 179 | $1,548 | $9 |
| Simvastatin | 126 | $1,529 | $12 |
| Amiodarone | 39 | $1,346 | $35 |
| Potassium Chloride | 39 | $1,090 | $28 |
| Pravastatin | 24 | $1,027 | $43 |
| Digox | 25 | $1,011 | $40 |
| Lisinopril | 141 | $980 | $7 |
| Isosorbide Mononitrate Er | 35 | $890 | $25 |
| Levothyroxine | 33 | $713 | $22 |
| Amlodipine Besylate | 71 | $634 | $9 |
| Losartan | 44 | $627 | $14 |
| Furosemide | 128 | $508 | $4 |
| Cartia Xt | 14 | $487 | $35 |
| Diltiazem Er | 17 | $483 | $28 |
| Omeprazole | 38 | $421 | $11 |
| Atenolol | 45 | $391 | $9 |
| Pantoprazole | 28 | $364 | $13 |
| Doxazosin Mesylate | 12 | $327 | $27 |
| Hydrocodone-Acetaminophen | 14 | $283 | $20 |
| Spironolactone | 31 | $247 | $8 |
| Famotidine | 17 | $245 | $14 |
| Gabapentin | 18 | $224 | $12 |
| Benazepril | 17 | $213 | $13 |
| Lovastatin | 14 | $207 | $15 |
| Hydrochlorothiazide | 27 | $178 | $7 |
| Allopurinol | 11 | $177 | $16 |
| Klor-Con M20 | 13 | $165 | $13 |
| Metformin | 11 | $100 | $9 |
| Lorazepam | 12 | $81 | $7 |
2013: 38 drugs
| Pradaxa | 65 | $29,311 | $451 |
| Xarelto | 26 | $9,697 | $373 |
| Sensipar | 13 | $8,809 | $678 |
| Clopidogrel | 118 | $4,747 | $40 |
| Diovan | 17 | $3,989 | $235 |
| Metoprolol | 41 | $3,282 | $80 |
| Atorvastatin | 79 | $3,136 | $40 |
| Carvedilol | 143 | $2,052 | $14 |
| Simvastatin | 118 | $1,590 | $13 |
| Warfarin | 129 | $1,376 | $11 |
| Metoprolol | 196 | $1,358 | $7 |
| Potassium Chloride | 32 | $1,222 | $38 |
| Lisinopril | 160 | $1,154 | $7 |
| Escitalopram | 11 | $1,080 | $98 |
| Isosorbide Dinitrate | 11 | $987 | $90 |
| Amlodipine Besylate | 92 | $871 | $9 |
| Isosorbide Mononitrate Er | 26 | $856 | $33 |
| Losartan | 41 | $818 | $20 |
| Cartia Xt | 13 | $633 | $49 |
| Pravastatin | 22 | $600 | $27 |
| Amiodarone | 36 | $546 | $15 |
| Furosemide | 97 | $531 | $5 |
| Digox | 48 | $478 | $10 |
| Omeprazole | 30 | $469 | $16 |
| Nitrostat | 13 | $389 | $30 |
| Atenolol | 40 | $351 | $9 |
| Levothyroxine | 21 | $325 | $15 |
| Pantoprazole | 24 | $314 | $13 |
| Benazepril | 26 | $310 | $12 |
| Alendronate | 17 | $305 | $18 |
| Metformin | 23 | $221 | $10 |
| Famotidine | 16 | $195 | $12 |
| Hydrochlorothiazide | 15 | $194 | $13 |
| Hydrocodone-Acetaminophen | 17 | $150 | $9 |
| Spironolactone | 16 | $145 | $9 |
| Allopurinol | 17 | $144 | $8 |
| Clonidine | 15 | $114 | $8 |
| Gabapentin | 14 | $79 | $6 |
Money from drug and device companies
$5,041 in 2025
| 2025 | 12 | 33 | $2,400 | $5,041 |
| 2024 | 10 | 26 | $2,100 | $12,957 |
| 2023 | 11 | 39 | $2,275 | $4,495 |
| 2022 | 16 | 41 | $1,500 | $3,831 |
| 2021 | 10 | 23 | $1,500 | $2,111 |
| 2020 | 8 | 29 | $1,125 | $2,450 |
| 2019 | 12 | 54 | $2,000 | $5,400 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $3,242 | 7 payments
|
| Abbott Laboratories | Aveir | $1,376 | 12 payments
|
| Novo Nordisk | Wegovy | $139 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $77 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $51 | 2 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $36 | 1 payment
|
See all 33 published payments
| Novartis Pharmaceuticals | Meals · 2025-11-09 | Leqvio | $77 |
| Abbott Laboratories | Meals · 2025-11-07 | Mitraclip | $28 |
| Biotronik | Meals · 2025-10-27 | Acticor 7 Vr-T Dx | $36 |
| Octapharma USA | Meals · 2025-10-22 | Balfaxar | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-21 | Kerendia | $25 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $53 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $33 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $75 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $32 |
| Abbott Laboratories | Travel · 2025-10-07 | Aveir | $203 |
| Medtronic | Consulting · 2025-10-03 | None | $2,400 |
| Novo Nordisk | Meals · 2025-09-30 | Wegovy | $13 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $151 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $732 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $33 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $9 |
| Pfizer | Meals · 2025-09-24 | Eliquis | $15 |
| Merck Sharp & Dohme | Meals · 2025-09-16 | Capvaxive | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-19 | Camzyos | $24 |
| Novo Nordisk | Meals · 2025-08-11 | Wegovy | $13 |
| Novo Nordisk | Meals · 2025-07-23 | Wegovy | $17 |
| Medtronic | Travel · 2025-06-20 | None | $299 |
| Medtronic | Travel · 2025-06-20 | None | $84 |
| Medtronic | Meals · 2025-06-20 | None | $91 |
| Medtronic | Meals · 2025-06-20 | None | $136 |
| Medtronic | Meals · 2025-06-20 | None | $63 |
| Sanofi-Aventis U.S. | Meals · 2025-04-15 | Tzield | $20 |
| Novo Nordisk | Meals · 2025-03-28 | Wegovy | $96 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| Edwards Lifesciences | Meals · 2025-03-04 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-21 | Kerendia | $26 |
| Abbott Laboratories | Meals · 2025-01-03 | Gallant | $11 |
| Abbott Laboratories | Meals · 2025-01-03 | Gallant | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $12,957
| Biotronik | Selectra | $10,364 | 7 payments
|
| Medtronic | Cobalt Dr Mri Surescan | $2,132 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $126 | 3 payments
|
| Abbott Laboratories | Gallant | $95 | 3 payments
|
| Amgen | Repatha | $70 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $67 | 2 payments
|
| Pfizer | Eliquis | $30 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $26 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $24 | 1 payment
|
| Boston Scientific | Watchman Flx | $23 | 1 payment
|
2023: $4,495
| Medtronic | Micra | $3,898 | 21 payments
|
| Abbott Laboratories | Jot Dx | $234 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $135 | 3 payments
|
| Lilly USA | Jardiance | $51 | 2 payments
|
| Amgen | Repatha | $37 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $33 | 1 payment
|
| Pfizer | Eliquis | $26 | 2 payments
|
| Atricure | Atriclip Laa Exclusion System | $23 | 1 payment
|
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $18 | 1 payment
|
| Boston Scientific | Watchman Flx | $16 | 1 payment
|
2022: $3,831
| Medtronic | Micra | $1,790 | 5 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $1,379 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $131 | 2 payments
|
| Boston Scientific | Watchman Access System | $93 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $73 | 1 payment
|
| Lilly USA | Jardiance | $73 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $58 | 3 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $43 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $41 | 2 payments
|
| Impulse Dynamics (USA) | Optimizer | $35 | 1 payment
|
| Amgen | Repatha | $34 | 2 payments
|
| Abbott Laboratories | Aveir | $22 | 1 payment
|
| Medicomp | Telepatch Cardiac Monitor | $17 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $16 | 1 payment
|
| Novo Nordisk | Rybelsus | $15 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $14 | 1 payment
|
2021: $2,111
| Medtronic | Micra | $1,698 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $180 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $54 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $34 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 1 payment
|
| AngioDynamics | Angiovac | $32 | 1 payment
|
| Boston Scientific | Watchman | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
| Pfizer | Eliquis | $17 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $12 | 1 payment
|
2020: $2,450
| Medtronic Vascular | Azure | $2,164 | 17 payments
|
| Biotronik | None | $158 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $33 | 2 payments
|
| Abbott Laboratories | Confirm Rx | $26 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $15 | 1 payment
|
| Boston Scientific | Accolade | $13 | 1 payment
|
2019: $5,400
| Medtronic Vascular | Visia Af | $3,471 | 25 payments
|
| Biotronik | None | $1,601 | 11 payments
|
| Janssen Pharmaceuticals | Xarelto | $70 | 5 payments
|
| Pfizer | Chantix | $62 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $46 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $39 | 2 payments
|
| Amgen | Repatha | $27 | 1 payment
|
| Abbott Laboratories | Fortify Assura, Ellipse Icd | $18 | 1 payment
|
| Lilly USA | Emgality | $18 | 1 payment
|
| Boston Scientific | General Brady | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $17 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
Checkups this office reported
20 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 49.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Adult Major Depressive Disorder (MDD): Suicide Risk AssessmentAs Medicare defines this measure | 0% | 93 |
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 100% | 52 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 38%That's less than half. | 24 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 65%That's more than half. | 435 |
| Breast cancer screeningEligible women who got a mammogram | 3%That's few of the people this applied to. | 175 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 3%That's few of the people this applied to. | 100 |
| Checked for fall riskOlder patients screened for fall risk | 7%That's few of the people this applied to. | 683 |
| Colon cancer screeningEligible adults who got a colon cancer test | 1%That's few of the people this applied to. | 478 |
See the other 12 measures
| Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 66% | 44 |
| Daily function assessedPatients whose ability to manage daily activities was assessed | 0%That's few of the people this applied to. | 125 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 890 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 154 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 80%That's most of the people this applied to. Worse on this measure. | 154 |
| Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 49% | 45 |
| Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 67% | 39 |
| Medications listed in the chartVisits where the current medication list was documented | 25%That's less than half. | 2,052 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 7%That's few of the people this applied to. Better on this measure. | 699 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 35% | 761 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 69%That's more than half. | 486 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 27%That's less than half. | 961 |
Professional record
- NPI
- 1992808992
- Licence
- CA A54174California A54174: Current · expires 2028-11-30
- Group
- California Cardiovascular Consultants · Washington Township Hospital District
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 215298
- Taxonomy
- Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 2333 Mowry Ave, Suite 300, Fremont, CA, 94538
- NPI first listed
- 2006-09-06
- NPI last updated
- 2021-08-24
- NPI record certified
- 2021-01-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2333 Mowry Ave, Fremont, CA, 94538 · 500 E Calaveras Blvd, Milpitas, CA, 95035